Galantamine for Alzheimer's disease

Expert Opinion on Drug Metabolism & Toxicology
David PrvulovicJohannes Pantel

Abstract

Alzheimer's disease (AD) is the most frequent, age-related neurodegenerative disorder and is characterized by progressive deterioration of cognition and global functioning. The relevance of the cholinergic system for memory, cognition and activities of daily life has been recognized decades ago, and research has demonstrated an early involvement and affection of central cholinergic pathways in the course of AD. Here, we review a body of placebo-controlled studies as well as meta-analyses on the cholinesterase (ChE) inhibitor galantamine, one of only four drugs currently approved for anti-dementia therapy in AD. The scope of this article is to concisely review the rationale of cholinergic treatment in AD, the chemistry and pharmacology of galantamine and to give a detailed overview of its clinical efficacy, safety, tolerability and potential usability for indications beyond AD. Galantamine can improve and stabilize cognitive performance, activities of daily living and behavioral symptoms over the course of 6 months and its efficacy and tolerability are comparable with those of other ChE inhibitors (rivastigmine and donepezil). As long as no other drug therapies with comparable or better clinical efficacy emerge, galantamine will...Continue Reading

References

Jun 1, 1978·Annals of Neurology·C M Smith, M Swash
Jan 1, 1992·Psychopharmacology·P A NewhouseR Lenox
Oct 1, 1991·Clinical Pharmacology and Therapeutics·U BickelH Kewitz
Jul 4, 1985·The New England Journal of Medicine·P T FrancisG K Wilcock
Nov 1, 1984·The American Journal of Psychiatry·W G RosenK L Davis
Jul 30, 1982·Science·R T BartusA S Lippa
May 1, 1995·Neurobiology of Aging·H Braak, E Braak
Jan 1, 1995·Journal of Neurochemistry·D H Small
Aug 11, 1994·European Journal of Pharmacology·M W DeckerS P Arnerić
Apr 6, 1994·JAMA : the Journal of the American Medical Association·P B WatkinsK W Lewis
Jan 1, 1996·International Psychogeriatrics·L S Schneider, J T Olin
Jan 8, 1999·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·A Nordberg, A L Svensson
Sep 29, 1999·The American Journal of Occupational Therapy : Official Publication of the American Occupational Therapy Association·I GélinasS Gauthier
Feb 16, 2000·Neurobiology of Aging·E GroberR B Lipton
Jun 20, 2000·Neurobiology of Aging·H AkiyamaT Wyss-Coray
Dec 29, 2000·Drugs·L J Scott, K L Goa
Sep 26, 2001·International Journal of Geriatric Psychiatry·D Wilkinson, J Murray
Oct 19, 2001·Journal of Neurology, Neurosurgery, and Psychiatry·K RockwoodD Wilkinson
Apr 16, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·G S J MannensW Meuldermans
Jun 14, 2002·Journal of Psychosomatic Obstetrics and Gynaecology·W MellerP Grambsch
Aug 7, 2002·Clinical Pharmacokinetics·Michael W JannGary W Small
Nov 28, 2002·Journal of Clinical Psychopharmacology·Valtteri KaasinenJuha O Rinne
Jul 24, 2003·Drugs & Aging·Gordon WilcockUNKNOWN GAL-GBR-2 Study Group
Feb 3, 2004·Current Pharmaceutical Design·Lutz FrölichHarald Hampel
May 4, 2004·The Journal of Pharmacology and Experimental Therapeutics·Shigeki MoriguchiToshio Narahashi
Jul 2, 2005·Dementia and Geriatric Cognitive Disorders·Henry BrodatyChandrasekhar Rao V Damaraju

❮ Previous
Next ❯

Citations

Jun 7, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Thomas J HopkinsHeath D Schmidt
Mar 12, 2013·TheScientificWorldJournal·Benoît Leclerc, Abedelnasser Abulrob
Feb 24, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Karolina A Wojtunik-KuleszaMonika Waksmundzka-Hajnos
Jun 5, 2013·Angewandte Chemie·Pierre-Yves DakasHerbert Waldmann
Mar 12, 2013·Neurobiology of Aging·Ina TesseurBart De Strooper
Feb 4, 2011·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Ralf IhlUNKNOWN WFSBP Task Force on Treatment Guidelines for Alzheimer's Disease and other Dementias
Jul 10, 2012·International Journal of Pharmaceutics·Chun-Woong ParkEun-Seok Park
Dec 7, 2011·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Vasudevan ManiAbu Bakar Abdul Majeed
Dec 12, 2012·American Journal of Alzheimer's Disease and Other Dementias·Xinling WangWei Chen
Mar 19, 2013·Therapeutic Drug Monitoring·Muriel NoetzliChin B Eap
Jun 20, 2019·Behavioral Sciences·María Andrea CastilloDario Siniscalco
Jul 9, 2020·Dose-response : a Publication of International Hormesis Society·You ZhouHaopeng Sun
Nov 22, 2020·Journal of Neurochemistry·Christine N Metz, Valentin A Pavlov
Dec 12, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Zeinab Breijyeh, Rafik Karaman
Feb 12, 2021·Bioorganic Chemistry·Pritam ThapaMukut Sharma
Jan 12, 2020·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Hussein AkelIldikó Csóka
Jun 18, 2021·Journal of Enzyme Inhibition and Medicinal Chemistry·Yinling YunXiaojing Wang
Jun 27, 2021·Analytical and Bioanalytical Chemistry·Mahmoud AgamiMarwa A A Ragab

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Expert Opinion on Investigational Drugs
Mercedes VillarroyaManuela G López
Clinical Interventions in Aging
Maria Luisa OnorEugenio Aguglia
The American Journal of Medicine
Martin R Farlow, Jeffrey L Cummings
© 2021 Meta ULC. All rights reserved